Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05296408 · ClinicalTrials.gov registry record · NA

Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits

A NA study of Chronic Stroke, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05296408: Recruiting NA study of Chronic Stroke, sponsored by VA Office of Research and Development.

NCT05296408 is a NA study of Chronic Stroke that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 60 participants, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05296408, a NA study of Chronic Stroke, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effects of combining motor learning-based therapy with use of the MyoPro , a wearable exoskeletal myoelectrically controlled orthotic device. MyoPro uses electromyographic (EMG) signals from the weak muscles to assist movement of the user's affected arm. The primary objective of this randomized controlled trial is to study the efficacy of using MyoPro in motor learning-based therapy for individuals with chronic stroke (\>6 months post) with severe upper limb motor deficits (Fugl-Meyer for Upper Limb score less than 30) compared with a similar dose of motor learning-based therapy alone. The secondary objectives are to evaluate neuroplasticity mechanisms, identify biomarkers of greater response to the intervention, and explore cost-effectiveness.

Primary Outcome

Thirty-three items of movement coordination and reflex activity are scored with a 3-point Likert scale (0-66 points) where higher scores represent better arm function.

Conditions Studied

Interventions

  • BEHAVIORAL Home Exercise Program
  • BEHAVIORAL motor learning based therapy
  • BEHAVIORAL MyoPro

Study Locations (1)

Ohio

  • Louis Stokes VA Medical Center, Cleveland, OH - Cleveland

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-04-01
Est. Completion 2026-04-01
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05296408 shows while recruiting

NCT05296408 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 41-participant average among 20 other Chronic Stroke trials with a reported enrollment target (46% higher).

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 3 interventions - of which Home Exercise Program is the first listed.

NCT05296408 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05296408 about?

NCT05296408 is a clinical study titled "Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits". This study will evaluate the effects of combining motor learning-based therapy with use of the MyoPro , a wearable exoskeletal myoelectrically controlled orthotic device. MyoPro uses electromyographic (EMG) signals from the weak muscles to assist movement of the user's affected arm. The primary obje...

What is the current status of trial NCT05296408?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-04-01. Estimated completion is 2026-04-01.

What conditions does trial NCT05296408 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT05296408?

The interventions under investigation include: Home Exercise Program (BEHAVIORAL), motor learning based therapy (BEHAVIORAL), MyoPro (BEHAVIORAL).

Who is sponsoring clinical trial NCT05296408?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05296408 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05296408's enrollment target sits among peer trials

60 4th of 20 higher than 16 of 20 other Chronic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05296408, the US trial registry maintained by the National Library of Medicine. NCT05296408 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.